Tsubota Laboratory Incorporated (TSE: 4890)
Health Care · Pharmaceuticals · JP
¥260.00
+3.59% today · -23.1% 1Y
Tsubota Laboratory Incorporated (TSE: 4890) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $42.35M and employs 22 people.
Over the last twelve months the share price has lost 23.1%, trading between 210.00 and 478.00.
Tweenvest scores Tsubota Laboratory Incorporated across four factors: quality 51/100, value 60/100, growth 0/100. Its strongest factor is value.
4890 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.35M
- Revenue (TTM)
- $2.40M
- P/E
- —
- EPS
- -26.89
- Dividend yield
- —
- Beta (5Y)
- 1.21
- 52-week high
- ¥478.00
- 52-week low
- ¥210.00
- Avg volume (3M)
- —
- Shares outstanding
- 25.79M
- Employees
- 22
- Next earnings
- —
About Tsubota Laboratory Incorporated
Operating from Tokyo, Japan since its establishment in 2012, Tsubota Laboratory Incorporated is dedicated to the research and development of pharmaceutical products and medical devices, specifically targeting the treatment of myopia, dry eyes, and presbyopia.
- ISIN
- JP3535700003
- Founded
- 2012
- Listed since
- Jun 23, 2022
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jenburkt Pharmaceuticals LimitedBSE: 524731 | $43.09M | Rs945.00 | +2.12% |
| Sofgen Pharma S.A.OTCPK: PROC.F | $43.07M | $— | — |
| Medicamen Biotech LimitedBSE: 531146 | $42.79M | Rs305.35 | -3.16% |
| Hayat Pharmaceutical Industries Co. PLCASE: HPIC | $42.48M | JD3.17 | -0.63% |
| Veru Inc.NasdaqCM: VERU | $41.94M | $2.41 | -2.24% |
| Orion Infusion LimitedDSE: ORIONINFU | $41.46M | Tk250.80 | -2.68% |
| Enzymatica AB (publ)OM: ENZY | $41.39M | Skr1.77 | +3.81% |
| Nasus Pharma Ltd.NYSEAM: NSRX | $41.12M | $3.43 | -2.28% |
Figures last refreshed Oct 11, 2026.